Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brian J Druker
Inhibition of the BCR-Abl Tyrosine Kinase as a Therapeutic Strategy for CML
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
BCR-ABL Tyrosine Kinase
Science-Business eXchange
Multidomain Targeting of BCR-Abl by Disruption of Oligomerization and Tyrosine Kinase Inhibition: Toward Eradication of CML
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Adherence to BCR-ABL Inhibitors: Issues for CML Therapy
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia
Haematologica
Hematology
Inhibition of BCR Serine Kinase by Tyrosine Phosphorylation.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Evolution of BCR/ABL Gene Mutation in CML Is Time Dependent and Dependent on the Pressure Exerted by Tyrosine Kinase Inhibitor
PLoS ONE
Multidisciplinary
Combined Inhibition of MDM2 and BCR-Abl Tyrosine Kinase Targets Chronic Myeloid Leukemia Stem/Progenitor Cells in a Murine Model
Haematologica
Hematology
A Multiple Reaction Monitoring (MRM) Method to Detect BCR-Abl Kinase Activity in CML Using a Peptide Biosensor
PLoS ONE
Multidisciplinary
Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
